Galimedix Therapeutics, Inc.
Yaniv Barkana serves as Chief Medical Officer at Galimedix Therapeutics, Inc. since April 2018 and co-founded I-OPtSens in 2020, where the role includes leading the clinical development of a permanent miniature intraocular device for intraocular pressure monitoring. Additionally, Yaniv Barkana has been an adviser for Eximore since September 2015 and co-directed the Glaucoma Innovation & Research Lab at Sheba Medical Center from 2020 to 2022. Prior experience includes a position as Tele-Glaucoma lead at Tzafon Medical Center and over 18 years as a senior ophthalmologist specializing in glaucoma at Assaf HaRofeh Medical Center. Academic contributions include serving as a senior clinical lecturer at Tel Aviv University from 2005 to 2015. Yaniv Barkana holds an MD from The Hebrew University of Jerusalem and completed a clinical fellowship in glaucoma at the New York Eye and Ear Infirmary.
This person is not in any teams
This person is not in any offices
Galimedix Therapeutics, Inc.
Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease.